TSH receptor mutations and thyroid disease

Trends in Endocrinology and Metabolism

Volumn 9, Issue 4, 1998, Pages 133-140

  Duprez, Laurence ^a   Parma, Jasmine ^b   Van Sande, Jacqueline ^a   Rodien, Patrice ^a   Dumont, Jacques E ^a   Vassart, Gilbert ^c   Abramowicz, Marc ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Inst Rech Interdisc Serv G   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR;

CONGENITAL HYPOTHYROIDISM; GENE MUTATION; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; NODULAR GOITER; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; THYROID ADENOMA; THYROID DISEASE; THYROID HYPERPLASIA; TOXIC GOITER;

EID: 0031745923     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00036-8     Document Type: Review

References (70)

1. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs C Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest. 99:1997;3018-3024.
2. Ahlbom BE, Yaqoob M, Larsson A, Ilicki A, Annerén G, Wadelius C Genetic and linkage analysis of familial congenital hypothyroidism: exclusion of linkage to the TSH receptor gene. Hum Genet. 99:1997;186-190.
3. Beamer WG, Eicher EM, Maltais LJ, Southard JL Inherited primary hypothyroidism in mice. Science. 212:1981;61-63.
4. Biebermann H, Gruters A, Schöneberg T, Gudermann T Congenital hypothyroidism caused by mutations in the thyrotropin-receptor gene. N Engl J Med. 336:1997;1390-1391.
5. Chazenbalk GD, Tanaka K, Nagayama Yet al. Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology. 138:1997;2893-2899.
6. Clifton-Bligh R, Gregory JW, John R, Chatterjee VKK Resistance to thyrotropin caused by two novel mutations in the TSH receptor gene [abst]. J Endocrinol Invest. 6(Supp):1996;68.
7. Cotecchia S, Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem. 267:1992;1633-1639.
8. Couet J, Sar S, Jolivet A, Hai MT, Milgrom E, Misrahi M Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease. J Biol Chem. 271:1996;4545-4552.
9. Couet J, de Bernard S, Loosfelt H, Saunier B, Milgrom E, Misrahi M Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry. 35:1996;14800-14805.
10. de Roux N, Polak M, Couet Jet al. Neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab. 81:1996;2023-2026.
11. de Roux N, Shields DC, Misrahi M, Ratanachaiyavong S, McGregor AM, Milgrom E Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab. 81:1996;3483-3486.
12. de Roux N, Misrahi M, Brauner Ret al. Four families with loss of function mutations of the thyrotropin receptor. J Clin Endocrinol Metab. 81:1996;4229-4235.
13. Djuh YY, Galvin M, Rhooms P, Tuttle M, Guthrie VM, Burch HB Screening for activating mutations of the human TSH-receptor in autonomously functioning thyroid nodules in a North American population [abst]. Thyroid. 6(Supp):1996;S-38.
14. Dremier S, Coppée F, Delange F, Vassart G, Dumont JE, Van Sande J Thyroid autonomy: mechanisms and clinical effects. J Clin Endocrinol Metab. 81:1996;4187-4193.
15. Dumont JE, Jauniaux JC, Roger PP The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci. 14:1989;67-71.
16. Dumont JE, Lamy F, Roger P, Maenhaut C Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 72:1992;667-697.
17. Duprez L, Parma J, Van Sande Jet al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet. 7:1994;396-401.
18. Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G, Parma J Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab. 82:1997;306-308.
19. Duprez L, Parma J, Costagliola Set al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the amino-terminal extracellular domain. FEBS Lett. 409:1997;469-474.
20. Esapa C, Betts P, Kendall-Taylor P, Harris PE A novel TSH receptor mutation in an infant with thyrotoxicosis (abst). J Endocrinol Invest. 6(Supp):1996;71.
21. Esapa C, Foster S, Johnson S, Jameson JL, Kendall-Taylor P, Harris PE G protein and thyrotropin receptor mutations in thyroid neoplasia. J Clin Endocrinol Metab. 82:1997;493-496.
22. Fradkin JE, Wolff J Iodide-induced thyrotoxicosis. Medicine. 62:1983;1-20.
23. Führer D, Willgerodt H, Scherbaum WA, Paschke R Identification of a new germline mutation in the thyrotropin receptor gene as a cause of familial nonautoimmune hyperthyroidism [abst]. Thyroid. 6(Supp 1):1996;S-60.
24. Führer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R Somatic mutations in the thyrotropin receptor gene and not in the Gsα protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab. 82:1997;3885-3891.
25. Gagné N, Parma J, Deal C, Vassart G, Van Vliet G, Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metab (in press).
26. Gross B, Misrahi M, Sar S, Milgrom E Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun. 177:1991;679-687.
27. Helmreich EJM, Hofmann KP Structure and function of proteins in G-protein-coupled signal transfer. Biochim Biophys Acta. 1286:1996;285-322.
28. Holzapfel HP, Wonerow P, van Petrykowski W, Henschen M, Scherbaum WA, Paschke R Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab. 82:1997;3879-3884.
29. Kajava AV, Vassart G, Wodak SJ Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure. 3:1995;867-877.
30. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ Constitutive activation of the alpha 1β-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem. 267:1992;1430-1433.
31. Kobe B, Deisenhofer J Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature. 366:1993;751-756.
32. Kobe B, Deisenhofer J A structural basis of the interactions between the leucine-rich repeat and protein ligands. Nature. 374:1995;183-186.
33. Kopp P, Muirhead S, Jourdain N, Jameson JL, Rodd C Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel mutation (serine281→isoleucine) in the extracellular domain of the TSH receptor. J Clin Invest. 100:1997;1634-1639.
34. Kopp P, Van Sande J, Parma Jet al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:1995;151-154.
35. Kosugi S, Mori T TSH receptor and LH receptor, 1995. Endocrine. J 42:1995;587-606.
36. Ledent C, Dumont JE, Vassart G, Parmentier M Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO. J 11:1992;537-542.
37. Lyons J, Landis CA, Harsh Get al. Two G protein oncogenes in human endocrine tumors. Science. 249:1990;655-659.
38. Macchia PE, Lapi P, Chiovati L, Busslinger M, Fenzi GF, Di Lauro R Identification of a mutation in the PAX-8 gene in a patient with thyroid ectopy [abst]. J Endocrinol Invest. 20(Supp):1997;84.
39. Matsuo K, Friedman E, Gejman PV, Fagin JA The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. J Clin Endocrinol Metab. 76:1993;1446-1451.
40. Michiels FM, Caillou B, Talbot Met al. Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid gland of transgenic mice. Proc Natl Acad Sci USA. 91:1994;10488-10492.
41. Nagayama Y, Rapoport B The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol. 6:1992;145-156.
42. Neer EJ Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257.
43. O'Dowd BF, Hnatowich M, Regan JW, Leader WM, Caron MG, Lefkowitz RJ Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J Biol Chem. 263:1988;15985-15992.
44. Parma J, Duprez L, Van Sande Jet al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:1993;649-651.
45. 2+ cascades. Mol Endocrinol. 9:1995;725-733.
46. Parma J, Duprez L, Van Sande Jet al. Diversity and prevalence of somatic mutations in the TSH receptor and Gαs genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 82:1997;2695-2701.
47. Parmentier M, Libert F, Maenhaut Cet al. Molecular cloning of the thyrotropin receptor. Science. 246:1989;1620-1622.
48. Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1994;1785-1789.
49. Paschke R, Fuehrer D, Holzapfel HP Identification of different somatic thyrotropin receptor mutations in toxic multinodular goiter [abst]. J Endocrinol Invest. 6(Supp):1996;28.
50. Patten JL, Johns DR, Valle Det al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 322:1990;1412-1419.
51. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab. 79:1994;657-661.
52. Porcellini A, Ciullo I, Pannain S, Fenzi G, Avvedimento VE Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas. Oncogene. 11:1995;1089-1093.
53. Robbins LS, Nadeau JH, Johnson KRet al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:1993;827-834.
54. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD Constitutively active mutants of Rhodopsin. Neuron. 9:1992;719-725.
55. Roger P, Reuse S, Maenhaut C, Dumont JE Multiple facets of the modulation of growth by cAMP. Vitam Horm. 51:1995;59-191.
56. Russo D, Arturi F, Schlumberger Met al. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11:1995;1907-1911.
57. Russo D, Arturi F, Chiefari E, Filetti S Molecular insights into TSH receptor abnormality and thyroid disease. J Endocrinol Invest. 20:1997;36-47.
58. Stein SA, Oates EL, Hall CRet al. Identification of a point mutation in the thyrotropin receptor of the hyL/hyL hypothyroid mouse. Mol Endocrinol. 8:1994;129-138.
59. Strader CD, Fong TM, Tota MR, Underwood D Structure and function of G protein-coupled receptors. Ann Rev Biochem. 63:1994;101-132.
60. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R gsp mutations in human thyroid tumours. Oncogene. 6:1991;677-679.
61. Sunthornthepvarakul T, Gottschalk M, Hayashi Y, Refetoff S Resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. N Engl J Med. 323:1995;155-160.
62. Takeshita A, Nagayama Y, Yokoyama Net al. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab. 80:1995;2607-2611.
63. Thomas JL, Leclère J, Hartemann Pet al. Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol. 100:1982;512-518.
64. Todd CH, Allain T, Gomo ZA, Hasler JA, Ndiweni M, Oken E Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe. Lancet. 346:1995;1563-1564.
65. Tonacchera M, Van Sande J, Parma Jet al. TSH receptor and disease. Clin Endocrinol. 44:1996;621-633.
66. Tonacchera M, Van Sande J, Cetani Fet al. Functional characteristics of three new germline mutations of the thyrotropin gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 8:1996;547-554.
67. Tonacchera M, Chiovato L, Fiore Eet al. Elevated incidence of TSH-R gene mutations in toxic adenoma and in hot nodules of toxic multinodular goiters [abst]. J Endocrinol Invest. 20(Supp):1997;4.
68. Van Sande J, Massart C, Costagliola Set al. Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol. 119:1996;161-168.
69. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab. 80:1995;2577-2585.
70. Vassart G, Dumont JE The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev. 13:1992;596-611.